Medifast (MED) Accumulated Expenses (2014 - 2020)

Medifast (MED) has 7 years of Accumulated Expenses data on file, last reported at $325000.0 in Q4 2020.

• Quarterly Accumulated Expenses fell 94.19% year-over-year to $325000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $325000.0 (down 94.19% YoY) and the FY2020 annual result came in at $325000.0, down 94.19% from the prior year.
• Accumulated Expenses slipped to $325000.0 in Q4 2020, from $5.6 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $10.6 million in Q4 2018 to a low of $121000.0 in Q4 2016.
• A 5-year average of $4.1 million and a median of $3.0 million in 2019 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2017 — Accumulated Expenses soared 6269.42% — and 2020, when it sank 94.19%.
• Tracing MED's Accumulated Expenses over 5 years: stood at $121000.0 in 2016, then soared by 6269.42% to $7.7 million in 2017, then jumped by 37.87% to $10.6 million in 2018, then tumbled by 47.32% to $5.6 million in 2019, then slumped by 94.19% to $325000.0 in 2020.
• The last three Accumulated Expenses figures came in at $325000.0 (Q4 2020), $5.6 million (Q4 2019), and $10.6 million (Q4 2018), per Business Quant data.